Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Accelerated Senescence of Fibroblast-Like Cells Derived from Induced Pluripotent Stem Cells of a Patient with Wiedemann-Rautenstrauch Progeroid Syndrome.

Created on 26 Oct 2026

Authors

Evgeniya A Orlova, Anna A Shchukina, Alla I Kalmykova

Published in

Biochemistry. Biokhimiia. Volume 91. Issue 10. Pages 2057-2070.

Abstract

The study of senescence dynamics in cells obtained from patients with accelerated aging syndromes provides a model for understanding the fundamental mechanisms of cellular senescence and for the search for approaches to slowing it down. Wiedemann-Rautenstrauch progeroid syndrome, caused by a mutation in the gene encoding the catalytic subunit of RNA polymerase III POLR3A, is a poorly studied syndrome with the earliest manifestation of accelerated aging features. Previously, we obtained induced pluripotent stem cells (iPSCs) from the fibroblasts of a patient with this syndrome. These iPSCs displayed changes in nucleolar structure, genome instability, and impairments in telomere maintenance mechanisms, as a result of which the telomeres did not elongate during reprogramming of the patient's fibroblasts into iPSCs. During iPSC differentiation, we obtained fibroblast-like cells (secondary fibroblasts), which were used to study dynamics of accelerated senescence. Expression of the mutant POLR3A was decreased in the secondary fibroblasts compared with the iPSCs; however, features of accelerated senescence were already detectable at early passages, manifested as increased β-galactosidase activity and increased expression of the cell-cycle inhibitor p16. Differentiation was accompanied by a pronounced shortening of telomere length, which had not been restored during the reprogramming of the patient's cells into iPSCs. The data obtained demonstrate that genomic instability of stem cells exerts an accelerating effect on the development of progeroid features during cellular differentiation.

PMID:
42927762
Bibliographic data and abstract were imported from PubMed on 26 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 14
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement